{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:02:14Z","timestamp":1794808934610,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008459","name":"University of Calgary","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["355993"],"award-info":[{"award-number":["355993"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Domestic Animal Endocrinology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.domaniend.2021.106620","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T21:29:10Z","timestamp":1613683750000},"page":"106620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy"],"prefix":"10.1016","volume":"76","author":[{"given":"H.E.","family":"Banse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.K.","family":"Chelikani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.domaniend.2021.106620_bib0001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tvjl.2018.03.002","article-title":"Epidemiology of pituitary pars intermedia dysfunction: a systematic literature review of clinical presentation, disease prevalence and risk factors","volume":"235","author":"Ireland","year":"2018","journal-title":"Vet J"},{"issue":"4","key":"10.1016\/j.domaniend.2021.106620_bib0002","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J Am Med Dir Assoc"},{"issue":"29","key":"10.1016\/j.domaniend.2021.106620_bib0003","doi-asserted-by":"crossref","first-page":"21074","DOI":"10.1074\/jbc.M113.456228","article-title":"Differential contribution of insulin and amino acids to the mTORC1-autophagy pathway in the liver and muscle","volume":"288","author":"Naito","year":"2013","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.domaniend.2021.106620_bib0004","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1152\/japplphysiol.00221.2002","article-title":"Invited review: role of insulin in translational control of protein synthesis in skeletal muscle by amino acids or exercise","volume":"93","author":"Kimball","year":"2002","journal-title":"J Appl Physiol"},{"issue":"6","key":"10.1016\/j.domaniend.2021.106620_bib0005","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2460\/ajvr.71.6.664","article-title":"Gene expression of proteolytic systems and growth regulators of skeletal muscle in horses with myopathy associated with pituitary pars intermedia dysfunction","volume":"71","author":"Aleman","year":"2010","journal-title":"Am J Vet Res"},{"issue":"7","key":"10.1016\/j.domaniend.2021.106620_bib0006","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2460\/ajvr.75.7.658","article-title":"Whole-body phenylalanine kinetics and skeletal muscle protein signaling in horses with pituitary pars intermedia dysfunction","volume":"75","author":"Mastro","year":"2014","journal-title":"Am J Vet Res"},{"issue":"11","key":"10.1016\/j.domaniend.2021.106620_bib0007","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.nmd.2006.07.019","article-title":"Myopathy in horses with pituitary pars intermedia dysfunction (Cushing's disease)","volume":"16","author":"Aleman","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.domaniend.2021.106620_bib0008","unstructured":"Freedom of information act new animal drug approval for Prascend. 2011 ; Available from: https:\/\/animaldrugsatfda.fda.gov\/adafda\/app\/search\/public\/document\/downloadFoi\/890. Accessed April 20, 2017."},{"issue":"6","key":"10.1016\/j.domaniend.2021.106620_bib0009","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/mus.21621","article-title":"Branched-chain amino acids protect against dexamethasone-induced soleus muscle atrophy in rats","volume":"41","author":"Yamamoto","year":"2010","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.domaniend.2021.106620_bib0010","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.2042-3306.1983.tb01826.x","article-title":"Relationship between condition score, physical measurements and body fat percentage in mares","volume":"15","author":"Henneke","year":"1983","journal-title":"Equine Vet J"},{"issue":"3-4","key":"10.1016\/j.domaniend.2021.106620_bib0011","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3920\/CEP12015","article-title":"Reliability of ultrasound-measured muscle thickness of the longissimus dorsi muscle in Thoroughbreds","volume":"8","author":"Abe","year":"2012","journal-title":"Compar Exer Physiol"},{"issue":"2","key":"10.1016\/j.domaniend.2021.106620_bib0012","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tvjl.2008.02.029","article-title":"Apparent adiposity assessed by standardised scoring systems and morphometric measurements in horses and ponies","volume":"179","author":"Carter","year":"2009","journal-title":"Vet J"},{"key":"10.1016\/j.domaniend.2021.106620_bib0013","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1152\/jappl.2001.91.5.2064","article-title":"Chronic clenbuterol administration acts as a repartitioning agent in horses","volume":"91","author":"Kearns","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.domaniend.2021.106620_bib0014","series-title":"Proceedings of the 10th Equine Nutrition and Physiology Symposium","article-title":"Estimating fatness in horses","author":"Kane","year":"1987"},{"issue":"3","key":"10.1016\/j.domaniend.2021.106620_bib0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/tvjl.2001.0656","article-title":"Fat-free mass is related to one-mile race performance in elite standardbred horses","volume":"163","author":"Kearns","year":"2002","journal-title":"Vet J"},{"issue":"4","key":"10.1016\/j.domaniend.2021.106620_bib0016","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2527\/jas1976.434781x","article-title":"Estimating fatness in horses and ponies","volume":"43","author":"Westervelt","year":"1976","journal-title":"J Anim Sci"},{"issue":"1","key":"10.1016\/j.domaniend.2021.106620_bib0017","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0749-0739(17)30165-7","article-title":"Spinal muscle pathology","volume":"15","author":"Valberg","year":"1999","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"1","key":"10.1016\/j.domaniend.2021.106620_bib0018","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1743-7075-9-90","article-title":"Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines","volume":"9","author":"Sharma","year":"2012","journal-title":"Nutr Metab"},{"issue":"1","key":"10.1016\/j.domaniend.2021.106620_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09781-2","article-title":"Whey protein components-lactalbumin and lactoferrin-improve energy balance and metabolism","volume":"7","author":"Zapata","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.domaniend.2021.106620_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-160145","article-title":"Skeletal muscle quantitative nuclear magnetic resonance imaging and spectroscopy as an outcome measure for clinical trials","volume":"3","author":"Carlier","year":"2016","journal-title":"J Neuromusc Dis"},{"issue":"3","key":"10.1016\/j.domaniend.2021.106620_bib0021","first-page":"217","article-title":"Relationship of skeletal muscle inflammation with obesity and obesity-associated hyperinsulinemia in horses","volume":"80","author":"Banse","year":"2016","journal-title":"Can J Vet Res"},{"issue":"7","key":"10.1016\/j.domaniend.2021.106620_bib0022","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2746\/042516402776250333","article-title":"Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide","volume":"34","author":"Perkins","year":"2002","journal-title":"Equine Vet J"},{"issue":"6","key":"10.1016\/j.domaniend.2021.106620_bib0023","first-page":"637","article-title":"Comparison of the glucose and insulin responses of horses to 2 formulations of corn syrup","volume":"60","author":"Moser","year":"2019","journal-title":"Can Vet J"},{"issue":"23","key":"10.1016\/j.domaniend.2021.106620_bib0024","doi-asserted-by":"crossref","first-page":"19094","DOI":"10.1074\/jbc.M111.322933","article-title":"Microtubule-associated protein 1 light chain 3 (LC3) interacts with Bnip3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy","volume":"287","author":"Hanna","year":"2012","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.domaniend.2021.106620_bib0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cmet.2007.11.001","article-title":"FoxO3 controls autophagy in skeletal muscle in vivo","volume":"6","author":"Mammucari","year":"2007","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.domaniend.2021.106620_bib0026","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.domaniend.2021.106620_bib0027","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00018-013-1513-z","article-title":"FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis","volume":"71","author":"Sanchez","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.domaniend.2021.106620_bib0028","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.freeradbiomed.2015.12.031","article-title":"The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass","volume":"98","author":"Rom","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.domaniend.2021.106620_bib0029","doi-asserted-by":"crossref","first-page":"E495","DOI":"10.1152\/ajpendo.00389.2016","article-title":"Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome","volume":"312","author":"Kang","year":"2017","journal-title":"Am J Physiol, Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.domaniend.2021.106620_bib0030","doi-asserted-by":"crossref","first-page":"e16674","DOI":"10.1371\/journal.pone.0016674","article-title":"Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1","volume":"6","author":"Biedasek","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.domaniend.2021.106620_bib0031","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2460\/ajvr.79.2.199","article-title":"Assessment of tissue-specific cortisol activity with regard to degeneration of the suspensory ligaments in horses with pituitary pars intermedia dysfunction","volume":"79","author":"Hofberger","year":"2018","journal-title":"Am J Vet Res"},{"issue":"11","key":"10.1016\/j.domaniend.2021.106620_bib0032","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/en.2018-00726","article-title":"Dysregulation of cortisol metabolism in equine pituitary pars intermedia dysfunction","volume":"159","author":"Morgan","year":"2018","journal-title":"Endocrinology"},{"issue":"25","key":"10.1016\/j.domaniend.2021.106620_bib0033","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1073\/pnas.251541198","article-title":"Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy","volume":"98","author":"Gomes","year":"2001","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.domaniend.2021.106620_bib0034","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3945\/jn.112.171967","article-title":"Short-term feed deprivation rapidly induces the protein degradation pathway in skeletal muscles of young mice","volume":"143","author":"Shavlakadze","year":"2013","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.domaniend.2021.106620_bib0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1159\/000095354","article-title":"Actions of short-term fasting on human skeletal muscle myogenic and atrogenic gene expression","volume":"50","author":"Larsen","year":"2006","journal-title":"Ann Nutr Metab"},{"issue":"8","key":"10.1016\/j.domaniend.2021.106620_bib0036","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00421-015-3148-2","article-title":"Skeletal muscle size is a major predictor of intramuscular fat content regardless of age","volume":"115","author":"Akima","year":"2015","journal-title":"Eur J Appl Physiol"},{"issue":"3","key":"10.1016\/j.domaniend.2021.106620_bib0037","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1519\/JPT.0b013e318236db92","article-title":"Age-and stroke-related skeletal muscle changes: a review for the geriatric clinician","volume":"35","author":"Sions","year":"2012","journal-title":"J Geriatr Phys Ther"},{"issue":"5","key":"10.1016\/j.domaniend.2021.106620_bib0038","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"issue":"7785","key":"10.1016\/j.domaniend.2021.106620_bib0039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.domaniend.2021.106620_bib0040","first-page":"EJ19","article-title":"Correlation among body composition and metabolic regulation in a male mouse model of Cushing's syndrome","author":"Uehara","year":"2019","journal-title":"Endocr J"},{"issue":"1","key":"10.1016\/j.domaniend.2021.106620_bib0041","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-3164.2012.01080.x","article-title":"Comparison of hair follicle histology between horses with pituitary pars intermedia dysfunction and excessive hair growth and normal aged horses","volume":"24","author":"Inner\u00e5","year":"2013","journal-title":"Vet Dermatol"},{"issue":"6","key":"10.1016\/j.domaniend.2021.106620_bib0042","first-page":"742","article-title":"Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease)","volume":"16","author":"Donaldson","year":"2002","journal-title":"J Vet Intern Med"},{"issue":"2","key":"10.1016\/j.domaniend.2021.106620_bib0043","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jvp.12339","article-title":"Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction","volume":"40","author":"McFarlane","year":"2017","journal-title":"J Vet Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.domaniend.2021.106620_bib0044","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.2042-3306.2011.00444.x","article-title":"Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction","volume":"44","author":"Copas","year":"2012","journal-title":"Equine Vet J"},{"issue":"2","key":"10.1016\/j.domaniend.2021.106620_bib0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0091-3057(85)90550-7","article-title":"Behavioral effects of pergolide mesylate on food intake and body weight","volume":"23","author":"Greene","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.domaniend.2021.106620_bib0046","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0404.2004.00364.x","article-title":"Does l-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?","volume":"111","author":"P\u00e5lhagen","year":"2005","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10.1016\/j.domaniend.2021.106620_bib0047","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1468-1331.2009.02617.x","article-title":"Dopaminergic treatment is associated with decreased body weight in patients with Parkinson's disease and dyskinesias","volume":"16","author":"Bachmann","year":"2009","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.domaniend.2021.106620_bib0048","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1353-8020(99)00017-6","article-title":"Long term role of pergolide as an adjunct therapy in Parkinson's disease: influence on disability, blood pressure, weight and levodopa syndrome","volume":"5","author":"Sharma","year":"1999","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.domaniend.2021.106620_bib0049","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jevs.2013.11.001","article-title":"Comparison of insulin and glucose metabolism in horses with pituitary pars intermedia dysfunction treated versus not treated with pergolide","volume":"34","author":"Gehlen","year":"2014","journal-title":"J Equine Vet Sci"}],"container-title":["Domestic Animal Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724021000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0739724021000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:26:31Z","timestamp":1778693191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0739724021000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":49,"alternative-id":["S0739724021000175"],"URL":"https:\/\/doi.org\/10.1016\/j.domaniend.2021.106620","relation":{},"ISSN":["0739-7240"],"issn-type":[{"value":"0739-7240","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy","name":"articletitle","label":"Article Title"},{"value":"Domestic Animal Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.domaniend.2021.106620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106620"}}